| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.04. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase | 6 | GlobeNewswire (USA) | ||
| 02.04. | Tonix Pharmaceuticals Holding Corp reports results for the quarter ended in December - Earnings Summary | 11 | Reuters | ||
| 01.04. | Tonix Pharmaceuticals GAAP EPS of -$0.86, revenue of $3.78M | 5 | Seeking Alpha | ||
| 01.04. | Tonix Pharmaceuticals Holding Corp. - 10-K, Annual Report | 2 | SEC Filings | ||
| 01.04. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights | 205 | GlobeNewswire (Europe) | Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya for fibromyalgia for NDA submission second half of 2024; pre-NDA meeting with FDA scheduled for... ► Artikel lesen | |
| 01.04. | Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On? | 4 | Benzinga.com | ||
| 29.03. | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | 5 | SEC Filings | ||
| 28.03. | Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated | 12 | Benzinga.com | ||
| 28.03. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering | 14 | GlobeNewswire (USA) | ||
| 20.03. | Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S. | 2 | Contract Pharma | ||
| 19.03. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024 | 133 | GlobeNewswire (Europe) | Zembrace® SymTouch® and Tosymra® will be marketed by Tonix Medicines, Tonix's wholly-owned commercial subsidiary Commercial capabilities prepare Tonix for the potential launch in 2025 of Tonmya for... ► Artikel lesen | |
| 19.03. | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 12.03. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring | 5 | GlobeNewswire (USA) | ||
| 07.03. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy | 1 | GlobeNewswire (USA) | ||
| 05.03. | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.03. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans | 63 | GlobeNewswire (Europe) | TNX-1500, a third generation anti-CD40L mAb, was Fc-modified to preserve the activity and bioavailability of first generation mAbs while addressing their thrombosis risk Sanofi projects its Fc-modified... ► Artikel lesen | |
| 27.02. | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 26.02. | Tonix Pharmaceuticals: New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain | 14.315 | ACCESSWIRE | Bedtime drug being developed by Tonix relieved pain by targeting fibromyalgia's characteristic "non-restorative sleep": Potential for FDA Approval in 2025CHATHAM, NJ / ACCESSWIRE / February 26, 2024... ► Artikel lesen | |
| 20.02. | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference | 1 | GlobeNewswire (USA) | ||
| 15.02. | Tonix Pharmaceuticals: Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction | 402 | ACCESSWIRE | Non-opioid drug candidate from Tonix lowered pain and also improved sleep and fatigueLatest Phase 3 trial achieved primary endpoint (p=0.00005)Potential for FDA Approval in 2025CHATHAM, NJ / ACCESSWIRE... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 1.749 |
| BAYER | 1.495 |
| NEL | 1.416 |
| TUI | 1.283 |
| PLUG POWER | 1.219 |
| NOVAVAX | 1.199 |
| SIEMENS ENERGY | 1.185 |
| MERCEDES-BENZ | 1.152 |
| PALANTIR TECHNOLOGIES | 818 |
| NVIDIA | 769 |
| ALLIANZ | 766 |
| RWE | 734 |
| DEUTSCHE BANK | 715 |
| BYD | 675 |
| BASF | 623 |
| DEUTSCHE LUFTHANSA | 607 |
| RHEINMETALL | 605 |
| TESLA | 574 |
| VOLKSWAGEN | 546 |
| COMMERZBANK | 535 |
| INFINEON | 535 |
| NORDEX | 502 |
| AIXTRON SE | 490 |
| RENK GROUP | 481 |
| STANDARD LITHIUM | 473 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
